Business Context and Reporting Period
Maison Solutions Inc. (MSS), a Delaware corporation, filed this Form 8-K on September 17, 2024. The company is listed on The Nasdaq Capital Market under the symbol MSS. This filing addresses a regulatory notice regarding the company's continued listing status.
Key Financial Metrics
This filing does not provide specific financial data such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on a listing deficiency notice.
Material Changes
The primary material event is the receipt of a Nasdaq Staff Deficiency Letter on September 17, 2024. The letter indicates that the company's common stock bid price closed below the minimum $1.00 per share requirement for 30 consecutive business days, violating Nasdaq Listing Rule 5550(a)(2).
Guidance, Outlook, and Risks
- Compliance Period: The company has been granted an initial 180-day period, ending March 17, 2025, to regain compliance.
- Compliance Criteria: To cure the deficiency, the bid price must close at $1.00 or more for 10 consecutive business days before the deadline.
- Future Options: If compliance is not achieved by March 17, 2025, the company may be eligible for an additional 180-day period, contingent on meeting other listing standards (e.g., market value of publicly held shares). The company may consider a reverse stock split to achieve compliance.
- Risks: There is no assurance the company will qualify for an additional compliance period or that Nasdaq will grant continued listing if a delisting notification is issued. The company may appeal any delisting determination.
- Current Status: The deficiency letter has no immediate effect on the listing or trading of the company's stock.
Investor Verification Checklist
- Verify the current bid price of MSS stock to assess proximity to the $1.00 threshold.
- Monitor the company's stock price for 10 consecutive days of trading at or above $1.00.
- Review upcoming filings for announcements regarding a potential reverse stock split.
- Check for any further correspondence from Nasdaq regarding the company's eligibility for a second compliance period.